Elevance Health, Inc.
ELV
$317.20
-$4.75-1.48%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.53B | 5.36B | 5.92B | 5.98B | 6.42B |
| Total Depreciation and Amortization | 804.00M | 746.00M | 701.00M | 659.00M | 734.00M |
| Total Amortization of Deferred Charges | 734.00M | 734.00M | 734.00M | 734.00M | 685.00M |
| Total Other Non-Cash Items | 612.00M | 393.00M | 11.00M | 154.00M | 351.00M |
| Change in Net Operating Assets | -2.77B | -779.00M | -2.52B | -1.72B | -6.06B |
| Cash from Operations | 4.91B | 6.45B | 4.85B | 5.81B | 2.13B |
| Capital Expenditure | -1.15B | -1.12B | -1.17B | -1.26B | -1.26B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.69B | -3.69B | -3.69B | -4.81B | -1.11B |
| Divestitures | 19.00M | 18.00M | 367.00M | 363.00M | 399.00M |
| Other Investing Activities | 1.37B | 2.16B | 1.74B | 535.00M | -2.59B |
| Cash from Investing | -3.45B | -2.62B | -2.75B | -5.17B | -4.56B |
| Total Debt Issued | 9.67B | 6.18B | 7.26B | 7.99B | 3.29B |
| Total Debt Repaid | -4.78B | -3.27B | -3.28B | -2.50B | -548.00M |
| Issuance of Common Stock | 39.00M | 87.00M | 147.00M | 221.00M | 245.00M |
| Repurchase of Common Stock | -3.98B | -3.18B | -3.35B | -3.01B | -2.12B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.53B | -1.52B | -1.52B | -1.51B | -1.48B |
| Other Financing Activities | 3.00M | -17.00M | -16.00M | 2.00M | 11.00M |
| Cash from Financing | -566.00M | -1.72B | -748.00M | 1.19B | -609.00M |
| Foreign Exchange rate Adjustments | -7.00M | 1.00M | -5.00M | -6.00M | 3.00M |
| Miscellaneous Cash Flow Adjustments | -46.00M | -45.00M | -66.00M | -66.00M | -20.00M |
| Net Change in Cash | 847.00M | 2.06B | 1.27B | 1.76B | -3.05B |